Enno Schmidt Selected Research

Immunoglobulin E (IgE)

3/2024	Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
1/2019	[Immunoadsorption in dermatology].
1/2018	Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.
1/2018	IgE-Selective Immunoadsorption for Severe Atopic Dermatitis.
1/2017	Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
1/2016	IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
12/2014	IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis.
8/2012	Immunoadsorption in dermatology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enno Schmidt Research Topics

Disease

124	Bullous Pemphigoid (Pemphigoid) 04/2024 - 01/2002
83	Pemphigus (Pemphigus Vulgaris) 04/2024 - 06/2002
41	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2023 - 06/2002
31	Blister (Bulla) 01/2023 - 04/2002
25	Skin Diseases (Skin Disease) 05/2023 - 04/2003
23	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 02/2008
15	Inflammation (Inflammations) 11/2023 - 01/2013
11	Neoplasms (Cancer) 04/2024 - 08/2010
8	Dermatitis Herpetiformis (Disease, Duhring's) 10/2023 - 04/2009
7	Acantholysis 04/2024 - 01/2009
7	Pemphigoid Gestationis (Herpes Gestationis) 12/2022 - 01/2002
6	Atopic Dermatitis (Atopic Eczema) 11/2020 - 08/2012
5	Linear IgA Bullous Dermatosis 02/2024 - 02/2012
5	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 01/2023 - 05/2008
4	Epidermolysis Bullosa 01/2022 - 12/2017
4	Cicatrix (Scar) 01/2021 - 02/2006
3	Infections 02/2024 - 05/2011
3	Pathologic Complete Response 12/2023 - 09/2005
3	Lichen Planus (Lichen Ruber Planus) 12/2022 - 01/2002
3	Nervous System Diseases (Neurological Disorders) 07/2022 - 12/2017
3	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 02/2018 - 05/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015 - 06/2002
3	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 09/2006 - 01/2002
2	Proteinuria 02/2024 - 06/2007
2	Fibrosis (Cirrhosis) 05/2023 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 11/2020
2	Pruritus (Itching) 01/2023 - 02/2012
2	Disease Progression 08/2021 - 02/2017
2	COVID-19 11/2020 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 04/2020
2	Hypersensitivity (Allergy) 01/2017 - 01/2010

Drug/Important Bio-Agent (IBA)

124	AutoantibodiesIBA 04/2024 - 01/2002
46	Immunoglobulin G (IgG)IBA 04/2024 - 04/2002
40	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2002
26	AntigensIBA 11/2023 - 04/2002
23	Collagen Type VIIIBA 10/2022 - 09/2006
23	AntibodiesIBA 01/2022 - 04/2002
20	KalininIBA 04/2024 - 06/2002
20	Rituximab (Mabthera)FDA Link 07/2023 - 02/2006
16	Matrix Metalloproteinases (MMPs)IBA 04/2024 - 09/2009
16	Collagen Type XVIIIBA 03/2024 - 01/2002
15	DesmogleinsIBA 04/2024 - 02/2009
12	Immunoglobulin A (IgA)IBA 02/2024 - 09/2006
11	Complement System Proteins (Complement)IBA 02/2024 - 04/2002
10	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 01/2004
10	Desmoglein 3IBA 01/2023 - 01/2004
8	Immunoglobulin E (IgE)IBA 03/2024 - 08/2012
7	Prednisolone (Predate)FDA LinkGeneric 04/2024 - 02/2006
7	Dapsone FDA Link 04/2024 - 09/2005
7	AutoantigensIBA 11/2023 - 01/2012
7	EnzymesIBA 01/2022 - 09/2007
6	Intravenous Immunoglobulins (IVIG)FDA Link 04/2024 - 01/2004
6	Desmosomal CadherinsIBA 04/2024 - 01/2009
6	Peptides (Polypeptides)IBA 01/2022 - 03/2009
6	EpitopesIBA 01/2022 - 04/2002
5	Therapeutic UsesIBA 04/2024 - 09/2011
5	Immunosuppressive Agents (Immunosuppressants)IBA 07/2022 - 09/2009
5	ImmunosorbentsIBA 04/2020 - 09/2007
5	Desmoglein 1IBA 11/2017 - 06/2009
4	Keratins (Keratin)IBA 04/2024 - 01/2009
4	Laminin (Merosin)IBA 03/2024 - 01/2012
4	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2023 - 04/2009
4	Immunoglobulin M (IgM)IBA 01/2023 - 01/2020
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 06/2007
4	Leukotriene B4IBA 11/2021 - 01/2017
4	SaltsIBA 11/2019 - 09/2006
4	Staphylococcal Protein A (Protein A)IBA 09/2018 - 01/2010
3	envoplakinIBA 04/2024 - 12/2009
3	CytokinesIBA 12/2023 - 02/2013
3	IgG Receptors (Fc gamma RI)IBA 11/2023 - 01/2017
3	TransglutaminasesIBA 10/2023 - 01/2011
3	Immunoglobulins (Immunoglobulin)IBA 02/2023 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017 - 09/2009
3	Doxycycline (Periostat)FDA LinkGeneric 01/2017 - 01/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2024 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 04/2024 - 02/2009
2	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2020
2	Immunodominant EpitopesIBA 11/2023 - 01/2013
2	neonatal Fc receptorIBA 11/2023 - 01/2020
2	GliadinIBA 10/2023 - 01/2013
2	apremilastIBA 02/2023 - 01/2023
2	Collagen Type I (Type I Collagen)IBA 01/2023 - 01/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 06/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 08/2014
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 02/2012
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 07/2015
2	CollagenIBA 01/2022 - 01/2011
2	Chemotactic FactorsIBA 03/2021 - 01/2017
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2021 - 09/2005
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2017
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2017
2	Complement C3 (C3 Complement)IBA 09/2019 - 01/2017
2	Omalizumab (Xolair)FDA Link 02/2018 - 01/2016
2	DesmocollinsIBA 12/2017 - 10/2009
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 07/2014
2	Protein Isoforms (Isoforms)IBA 12/2017 - 12/2017
2	Etanercept (Enbrel)FDA Link 02/2017 - 09/2011

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2004
2	Aftercare (After-Treatment) 04/2024 - 09/2018